Melanotan 2 10mg Canada

Technical Specifications

Compound Name: Melanotan 2 (MT-2)
Quantity: 10mg per vial
Format: Lyophilized peptide powder
Peptide Length: 7 amino acids (cyclic heptapeptide analogue)
Molecular Weight: Approximately 1024.2 g/mol
Purity Standard: ≥98% (HPLC, batch dependent)
Research Classification: Investigational peptide – laboratory research use only

Melanotan 2 10mg Canada is supplied as a lyophilized synthetic peptide intended exclusively for laboratory and analytical applications. Each vial contains 10 milligrams of the cyclic melanocortin analogue prepared under controlled handling and quality verification standards appropriate for research material distribution.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada when supplied in research format.

Research Overview

Melanotan 2 is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) and is designed to interact with melanocortin receptors in experimental systems. It has been studied in the context of endocrinology and receptor biology research for its activity at melanocortin receptor subtypes.

Research on Melanotan 2 10mg Canada typically focuses on melanocortin receptor signalling, activation of the cyclic AMP pathway, and downstream gene expression in laboratory settings. The scientific literature describes MT-2 as a non-selective agonist at melanocortin receptors, particularly MC1R, MC3R, MC4R, and MC5R, in experimental models.

Preclinical investigations have evaluated receptor binding affinity, intracellular signalling responses, and physiological pathway activation in controlled laboratory conditions. Animal models and in vitro assays are frequently used to assess receptor activation kinetics and signal transduction patterns.

Melanotan 2 10mg Canada is supplied strictly for research purposes. All references to receptor pathways reflect investigational findings and do not imply authorized therapeutic application of the research-grade material.

Mechanism Overview

Melanotan 2 is a cyclic heptapeptide analogue structurally related to α-MSH. In laboratory studies, it has been shown to bind to melanocortin receptors, which are G-protein–coupled receptors involved in pigmentation, energy regulation, and endocrine signalling pathways.

Upon activation in experimental systems, melanocortin receptors stimulate adenylate cyclase, increasing intracellular cyclic AMP levels and activating downstream transcription factors. Researchers analyzing Melanotan 2 10mg Canada typically measure receptor affinity, second-messenger production, and gene-expression markers in cell-based assays.

Because MT-2 is not fully selective for a single melanocortin receptor subtype, experimental studies often examine differential receptor activation profiles and cross-reactivity patterns. Mechanistic descriptions remain confined to preclinical and investigational data and are presented for educational purposes only.

Clinical Development Context

Melanotan 2 has been studied in early-stage clinical research examining melanocortin receptor biology and endocrine responses. Published literature includes controlled investigations assessing pharmacokinetic and pharmacodynamic properties.

Despite its presence in scientific research, Melanotan 2 10mg Canada, supplied in research-grade format, is categorized strictly as an investigational laboratory compound. It is distinct from anauthorizeded pharmaceutical preparation and is not approved by Health Canada as a prescription medication or consumer product when provided as a research material.

Ongoing scientific interest in melanocortin analogues continues within endocrinology and receptor pharmacology research institutions.

Regulatory Status in Canada

Melanotan 2 10mg Canada is classified as an investigational research peptide. It is not authorized by Health Canada as a therapeutic drug, natural health product, or over-the-counter medication when supplied in research format.

The peptide is provided exclusively for laboratory and analytical purposes and is not intended for human or veterinary administration.

Handling, storage, and study of Melanotan 2 10mg in Canada must comply with applicable federal and provincial Canadian regulations governing chemical and biological research materials. Laboratories and research institutions are responsible for maintaining regulatory compliance.

Molecular and Structural Notes

Melanotan 2 is a cyclic peptide derived from the α-MSH sequence, with structural modifications that increase receptor-binding affinity and metabolic stability in experimental systems. Cyclization of the peptide backbone enhances resistance to enzymatic degradation.

With a molecular weight of approximately 1024.2 g/mol, Melanotan 2 is larger than short tripeptides but smaller than many full-length hormone analogues. Its structure includes a D-phenylalanine substitution that influences receptor interaction characteristics observed in laboratory studies.

Melanotan 2 10mg Canada is typically characterized using analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry to confirm identity and purity before distribution.

The lyophilized format supports peptide stability during storage when maintained under appropriate laboratory conditions.

Frequently Asked Questions

What is Melanotan 2 10mg Canada studied for in research?
Melanotan 2 10mg in Canada is studied in laboratory settings to investigate melanocortin receptor signalling and related endocrine pathways.

Is Melanotan 2 approved for medical use in Canada?
Health Canada does not authorize research-grade Melanotan 2 for therapeutic or consumer use.

What type of peptide is Melanotan 2?
It is a cyclic synthetic analogue of alpha-melanocyte-stimulating hormone, studied in receptor pharmacology research.

Does Melanotan 2 10mg Canada contain additives?
Unless specified in the attached documentation, the vial contains only the lyophilized peptide compound.

Can Melanotan 2 10mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.

Educational Disclaimer

Melanotan 2 10mg Canada is an investigational research peptide supplied solely for laboratory and analytical use. It is not approved by Health Canada as a medication, therapeutic agent, or consumer product when provided in research-grade form.

Information provided on this page is educational in nature and based on publicly available scientific literature describing investigational research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of Melanotan 2 10mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.